These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36260973)

  • 1. Hypoxia adapted relative biological effectiveness models for proton therapy: a simulation study.
    Garrido-Hernandez G; Henjum H; Høiskar MK; Dahle TJ; Redalen KR; Ytre-Hauge KS
    Biomed Phys Eng Express; 2022 Nov; 8(6):. PubMed ID: 36260973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined RBE and OER optimization in proton therapy with FLUKA based on EF5-PET.
    Henjum H; Dahle TJ; Mairani A; Pilskog S; Stokkevåg C; Boer CG; Redalen KR; Minn H; Malinen E; Ytre-Hauge KS
    J Appl Clin Med Phys; 2023 Sep; 24(9):e14014. PubMed ID: 37161820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FLUKA Monte Carlo code coupled with an OER model for biologically weighted dose calculations in proton therapy of hypoxic tumors.
    Dahle TJ; Rusten E; Stokkevåg CH; Silvoniemi A; Mairani A; Fjæra LF; Rørvik E; Henjum H; Wright P; Boer CG; Forsback S; Minn H; Malinen E; Ytre-Hauge KS
    Phys Med; 2020 Aug; 76():166-172. PubMed ID: 32683269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-informed RBE-weighted beam orientation optimization for intensity modulated proton therapy.
    Ramesh P; Ruan D; Liu SJ; Seo Y; Braunstein S; Sheng K
    Med Phys; 2024 Mar; 51(3):2320-2333. PubMed ID: 38345134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour control in ion beam radiotherapy with different ions in the presence of hypoxia: an oxygen enhancement ratio model based on the microdosimetric kinetic model.
    Strigari L; Torriani F; Manganaro L; Inaniwa T; Dalmasso F; Cirio R; Attili A
    Phys Med Biol; 2018 Mar; 63(6):065012. PubMed ID: 28862152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
    Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
    Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LET-weighted doses effectively reduce biological variability in proton radiotherapy planning.
    McMahon SJ; Paganetti H; Prise KM
    Phys Med Biol; 2018 Nov; 63(22):225009. PubMed ID: 30412471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of hypoxia on LET and RBE relationships with implications for ultra-high dose rates and FLASH modelling.
    Jones B
    Phys Med Biol; 2022 Jun; 67(12):. PubMed ID: 35545062
    [No Abstract]   [Full Text] [Related]  

  • 11. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential.
    Giantsoudi D; Grassberger C; Craft D; Niemierko A; Trofimov A; Paganetti H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):216-22. PubMed ID: 23790771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical dose assessment for scanned carbon-ion radiotherapy using linear energy transfer measurements and Monte Carlo simulations.
    Nakaji T; Kanai T; Takashina M; Matsumura A; Osaki K; Yagi M; Tsubouchi T; Hamatani N; Ogawa K
    Phys Med Biol; 2022 Dec; 67(24):. PubMed ID: 36327456
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploration and application of phenomenological RBE models for proton therapy.
    Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
    Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of potentially variable RBE in liver proton therapy.
    Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
    Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in LET-based biological doses between IMPT optimization techniques: Robust and PTV-based optimizations.
    Hirayama S; Matsuura T; Yasuda K; Takao S; Fujii T; Miyamoto N; Umegaki K; Shimizu S
    J Appl Clin Med Phys; 2020 Apr; 21(4):42-50. PubMed ID: 32150329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
    Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
    Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phenomenological relative biological effectiveness approach for proton therapy based on an improved description of the mixed radiation field.
    Mairani A; Dokic I; Magro G; Tessonnier T; Bauer J; Böhlen TT; Ciocca M; Ferrari A; Sala PR; Jäkel O; Debus J; Haberer T; Abdollahi A; Parodi K
    Phys Med Biol; 2017 Feb; 62(4):1378-1395. PubMed ID: 28114106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Monte Carlo based radiation response modelling framework to assess variability of clinical RBE in proton therapy.
    Eulitz J; Lutz B; Wohlfahrt P; Dutz A; Enghardt W; Karpowitz C; Krause M; Troost EGC; Lühr A
    Phys Med Biol; 2019 Nov; 64(22):225020. PubMed ID: 31374558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.